| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/17/2023 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 77k | $11.34 | $873.2k | | 02/17/2023 |
| 02/17/2023 | Cullinan Oncology, Inc. | | Grant | Common Stock | 38.5k | $0.00 | $0 | | 02/17/2023 |
| 02/11/2022 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 75k | $13.60 | $1M | | 02/11/2022 |
| 02/11/2022 | Cullinan Oncology, Inc. | | Grant | Common Stock | 37.5k | $0.00 | $0 | | 02/11/2022 |
| 09/08/2021 | Cullinan Oncology, Inc. | | Exercise | Stock Option (Right to Buy) | 11k | $4.30 | $47.3k | | 09/08/2021 |
| 09/08/2021 | Cullinan Oncology, Inc. | | Sale | Common Stock | 11k | $28.45 | $313k | | 09/08/2021 |
| 08/10/2021 | Cullinan Oncology, Inc. | | Sale | Common Stock | 11k | $27.00 | $297k | | 08/10/2021 |
| 08/10/2021 | Cullinan Oncology, Inc. | | Exercise | Stock Option (Right to Buy) | 11k | $4.30 | $47.3k | | 08/10/2021 |
| 01/07/2021 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 286.7k | $21.00 | $6M | | 01/07/2021 |
| 12/10/2020 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 12.1k | $31.83 | $385.1k | | 12/10/2020 |
| 05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $20.59 | $209.3k | | 05/28/2020 |
| 05/28/2020 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 2.6k | $20.59 | $53.2k | | 05/28/2020 |
| 12/27/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common Stock | 75.6k | $15.81 | $1.2M | See footnote | 12/27/2019 |
| 12/27/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common Stock | 10.4k | $16.90 | $176.1k | See footnote | 12/27/2019 |
| 12/27/2019 | Harpoon Therapeutics, Inc. | HARP | Sale | Common Stock | 1.4k | $18.07 | $25.3k | See footnote | 12/27/2019 |
| 12/23/2019 | TCR2 THERAPEUTICS INC. | TCRR | Sale | Common Stock | 84.9k | $15.44 | $1.3M | By APAK Solutions GmbH | 12/20/2019 |
| 12/20/2019 | TCR2 THERAPEUTICS INC. | TCRR | Sale | Common Stock | 32k | $15.16 | $485.5k | By APAK Solutions GmbH | 12/20/2019 |
| 06/03/2019 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 10.2k | $11.84 | $120.4k | | 06/03/2019 |
| 04/11/2019 | TCR2 THERAPEUTICS INC. | TCRR | Grant | Stock Option (Right to Buy) | 59.8k | $16.11 | $964.2k | | 04/11/2019 |
| 02/07/2019 | Harpoon Therapeutics, Inc. | HARP | Grant | Director Stock Option (Right to Buy) | 3.8k | $14.00 | $53.6k | | 02/07/2019 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 180k | $8.08 | $1.5M | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 165k | $5.83 | $962k | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 62.5k | $3.16 | $197.5k | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 32.1k | $1.75 | $56.3k | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 300k | $2.56 | $768k | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 100k | $1.75 | $175k | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 272.3k | $1.66 | $451.9k | | 03/07/2012 |
| 03/07/2012 | MICROMET, INC. | MITI | Disposition | Stock Option (right to buy) | 36.5k | $3.16 | $115.2k | | 03/07/2012 |
| 01/29/2010 | MICROMET, INC. | MITI | Grant | Stock Option (right to buy) | 36.5k | $3.16 | $115.2k | | 01/29/2010 |